A detailed history of Edentree Asset Management LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Edentree Asset Management LTD holds 120,300 shares of BSX stock, worth $9.82 Million. This represents 2.94% of its overall portfolio holdings.

Number of Shares
120,300
Previous 134,542 10.59%
Holding current value
$9.82 Million
Previous $9.21 Billion 0.58%
% of portfolio
2.94%
Previous 2.92%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $958,913 - $1.11 Million
-14,242 Reduced 10.59%
120,300 $9.27 Billion
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $1.25 Million - $1.49 Million
-21,733 Reduced 13.91%
134,542 $9.21 Billion
Q4 2023

Feb 13, 2024

BUY
$48.64 - $57.81 $1.42 Million - $1.69 Million
29,275 Added 23.05%
156,275 $9.03 Billion
Q2 2023

Aug 11, 2023

BUY
$49.72 - $54.64 $6.31 Million - $6.94 Million
127,000 New
127,000 $6.87 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $117B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Edentree Asset Management LTD Portfolio

Follow Edentree Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edentree Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Edentree Asset Management LTD with notifications on news.